Treatment of Diamond-Blackfan anemia with recombinant human interleukin-3.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Blood

• Publication date

  1993-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD.V82.3.744.BLOODJOURNAL823744PMID 8338944
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The SCF and c-kit genes in Diamond-Blackfan anemia.

  1992cited by this paper
• Effect of stem cell factor on in vitro erythropoiesis in patients with bone marrow failure syndromes.

  1992cited by this paper
• Absence of abnormalities of c-kit or its ligand in two patients with Diamond-Blackfan anemia.

  1992cited by this paper
• Diamond-Blackfan anemia: heterogenous response of hematopoietic progenitor cells in vitro to the protein product of the steel locus.

  1991cited by this paper
• Treatment of Diamond‐Blackfan anaemia with haematopoietic growth factors, granulocyte‐macrophage colony stimulating factor and interleukin 3: sustained remissions following IL‐3

  1991cited by this paper
• In vitro growth and regulation of bone marrow enriched CD34+ hematopoietic progenitors in Diamond-Blackfan anemia.

  1991cited by this paper
• Phase I study of recombinant human interleukin-3 in patients with bone marrow failure.

  1991cited by this paper
• Effects of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure.

  1990cited by this paper
• Effects of recombinant human interleukin-3 in patients with myelodysplastic syndromes.

  1990cited by this paper
• Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor

  1990cited by this paper
• Diamond-Blackfan anemia: promotion of marrow erythropoiesis in vitro by recombinant interleukin-3.

  1989cited by this paper
• Diamond-blackfan anemia: etiology, pathophysiology, and treatment.

  1989cited by this paper
• An intrinsic progenitor defect in Diamond‐Blackfan anaemia

  1989cited by this paper
• Synergism between erythropoietin and interleukin-3 in the induction of hematopoietic stem cell proliferation and erythroid burst colony formation.

  1988cited by this paper
• Failure of recombinant human granulocyte-macrophage colony-stimulating factor therapy in aplastic anemia patients with very severe neutropenia.

  1988cited by this paper
• The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene.

  1988cited by this paper
• Erythroid burst-promoting activity of purified recombinant human GM-CSF and interleukin-3: studies with anti-GM-CSF and anti-IL-3 sera and studies in serum-free cultures.

  1988cited by this paper
• Bone marrow transplantation for constitutional pure red cell aplasia.

  1988cited by this paper
• Eosinophils : a comprehensive review, and guide to the scientific and medical literature

  1988cited by this paper
• Defective erythroid progenitor differentiation system in congenital hypoplastic (Diamond-Blackfan) anemia.

  1986cited by this paper
• Human IL-3 (multi-CSF): identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3.

  1986cited by this paper
• Complete recovery of hemopoiesis following bone marrow transplant in a patient with unresponsive congenital hypoplastic anemia (Blackfan-Diamond syndrome).

  1984cited by this paper
• Congenital hypoplastic anemia (Diamond-Blackfan syndrome).

  1982cited by this paper
• NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations.

  1982cited by this paper
• Cytotoxic properties of the eosinophil major basic protein.

  1979cited by this paper
• Erythroid precursors in congenital hypoplastic (Diamond-Blackfan) anemia.

  1978cited by this paper
• Erythroid colony growth in congenital hypoplastic anemia.

  1976cited by this paper
• Establishment of erythropoiesis following bone marrow transplantation in a patient with congenital hypoplastic anemia (Diamond-Blackfan syndrome).

  1976cited by this paper

• Diamond–Blackfan anemia with mutation in RPS19: A case report and an overview of published pieces of literature

  2020cites this paper
• B-ALL With t(5;14)(q31;q32); IGH-IL3 Rearrangement and Eosinophilia: A Comprehensive Analysis of a Peculiar IGH-Rearranged B-ALL

  2019cites this paper
• On new and current treatments for Diamond-Blackfan anemia

  2018cites this paper
• How I manage children with Diamond‐Blackfan anaemia

  2018cites this paper
• Diamond-Blackfan Anemia

  2018cites this paper
• and Cyclosporin Therapy Results Study of 22 Egyptian Patients With Diamond-Blackfan Anemia, Corticosteroids,

  2013cites this paper
• role for prolactin in erythropoiesis Response of Diamond-Blackfan anemia to metoclopramide: evidence for a

  2013cites this paper
• Progress towards Mechanism-Based Treatment for Diamond-Blackfan Anemia

  2012cites this paper
• Frameshift mutation in p53 regulator RPL26 is associated with multiple physical abnormalities and a specific pre‐ribosomal RNA processing defect in diamond–blackfan anemia

  2012cites this paper
• Pulmonary embolism after snake bite in a child with Diamond-Blackfan anemia.

  2011cites this paper
• microarray dexamethasone: identification of dexamethasone-responsive genes by anemia recapitulates defective hematopoiesis and rescue by An RNA interference model of RPS19 deficiency in Diamond-Blackfan

  2010cites this paper
• How I treat Diamond-Blackfan anemia.

  2010cites this paper
• Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference

  2008cites this paper
• Diamond-Blackfan anemia: long-term follow-up of six cases

  2008cites this paper
• Hematopoietic growth factors for the treatment of inherited cytopenias.

  2007cites this paper
• Hematopoietic Stem-Cell Transplantation for the Inherited Bone Marrow Failure Syndromes

  2006cites this paper
• A CONGENITAL DEFECT IN ERYTHROPOIESIS

  2005cites this paper
• Successful treatment of Diamond‐Blackfan anemia with metoclopramide

  2005cites this paper
• An RNA interference model of RPS19 deficiency in Diamond-Blackfan anemia recapitulates defective hematopoiesis and rescue by dexamethasone: identification of dexamethasone-responsive genes by microarray.

  2004cites this paper
• Study of 22 Egyptian patients with Diamond-Blackfan anemia, corticosteroids, and cyclosporin therapy results.

  2002cites this paper
• The Effect of Thrombopoietin on Erythroid Progenitors in Diamond-Blackfan Anemia

  2002cites this paper
• Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation.

  2002cites this paper
• Diamond-Blackfan anaemia.

  2000cites this paper
• Diamond-Blackfan anemia.

  2000cites this paper
• Diamond-Blackfan Anaemia

  2000cites this paper
• Cytokines for the Treatment of Myelodysplastic Syndromes and Other Bone Marrow Failure States

  1999cites this paper
• Interleukin-3 in hematology and oncology: current state of knowledge and future directions.

  1999cites this paper
• Phase I/II trial of PIXY321 (granulocyte‐macrophage colony stimulating factor/interleukin‐3 fusion protein) for treatment of inherited and acquired marrow failure syndromes

  1998cites this paper
• Interleukin-3: Promises and Perspectives.

  1998cites this paper
• IL‐3 in the Clinic

  1997cites this paper
• Diamond-Blackfan anemia: expansion of erythroid progenitors in vitro by IL-9, but exclusion of a significant pathogenetic role for the IL-9 gene and the hematopoietic gene cluster on chromosome 5q.

  1997cites this paper
• Diamond-Blackfan anaemia in a girl with a de novo balanced reciprocal X;19 translocation.

  1997cites this paper
• Diamond-Blackfan anemia.

  1997cites this paper
• Diamond Blackfan anaemia: differential pattern of in vitro progenitor response to macrophage inflammatory protein 1‐alpha

  1996cites this paper
• Diamond-Blackfan anemia: a congenital defect in erythropoiesis.

  1996cites this paper
• Mutations in the erythropoietin receptor gene are not a common cause of Diamond-Blackfan anemia.

  1996cites this paper
• Diamond-Blackfan anemia. Natural history and sequelae of treatment.

  1996cites this paper
• In vitro progenitor analysis in a Diamond Blackfan anaemia patient who responded once but not twice to interleukin‐3 therapy, using short‐term and long‐term cultures and c‐kit analysis

  1996cites this paper
• Interleukin-3 and its receptor.

  1995cites this paper
• Bone marrow failure: pathophysiology and management.

  1995cites this paper
• Diamond‐Blackfan anaemia: three patterns of in vitro response to haemopoietic growth factors

  1995cites this paper
• Clinical Toxicity of Cytokines Used As Haemopoietic Growth Factors

  1995cites this paper
• High-dose intravenous methylprednisolone therapy for patients with Diamond-Blackfan anemia refractory to conventional doses of prednisone.

  1995cites this paper
• IL‐3 increases marrow and peripheral erythroid precursors in chronic pure red cell aplasia presenting in childhood

  1995cites this paper
• Is there a role for interleukin‐3 in Diamond‐Blackfan anaemia? Results of a European multicentre study

  1995cites this paper
• Bone marrow transplantation for Diamond-Blackfan anemia.

  1995cites this paper
• Interleukin-3

  1995cites this paper
• Evaluation of granulocyte-macrophage colony-stimulating factor for treatment of pancytopenia in children with fanconi anemia.

  1994cites this paper
• Acute arterial thrombosis in a patient with breast cancer after chemotherapy with 5‐fluorouracil, doxorubicin, leucovorin, cyclophosphamide, and interleukin‐3

  1994cites this paper
• Age‐related alterations in erythroid and granulopoietic progenitors in Diamond‐Blackfan anaemia

  1994cites this paper
• Transfusion support of hematology and oncology patients. The role of recombinant hematopoietic growth factors.

  1994cites this paper
• Sustained response after recombinant interleukin-3 in diamond blackfan anemia.

  1994cites this paper
• Erythroid failure in Diamond-Blackfan anemia is characterized by apoptosis.

  1994cites this paper
• Present and future clinical relevance of interleukin 3

  1994cites this paper